|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Open Access
Best Reviewer Awardees
Article Processing Charge
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Agreement
All issues
Accepted Articles
Epub Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Cancer Research and Treatment
Search
Author Index
Cancer Research and Treatment
Search
> Browse Articles > Search
Hematologic malignancy
Feasibility of Circulating Tumor DNA Analysis in Patients with Follicular Lymphoma
Sang Eun Yoon, Seung-Ho Shin, Dae Keun Nam, Junhun Cho, Won Seog Kim, Seok Jin Kim
Cancer Res Treat.
2024;56(3):920-935. Published online January 16, 2024 DOI:
https://doi.org/10.4143/crt.2023.869
Crossref 1
Lung and Thoracic cancer
Analytical and Clinical Validation of a Highly Sensitive NGS-Based ctDNA Assay with Real-World Concordance in Non–Small Cell Lung Cancer
Hanbaek Yi, Jeonghwan Youk, Yoojoo Lim, Hanseong Roh, Dongsoo Kyung, Hwang-Phill Kim, Duhee Bang, Bhumsuk Keam, Tae-Min Kim, Miso Kim, Dong-Wan Kim, Tae-You Kim
Cancer Res Treat.
2024;56(3):765-773. Published online January 8, 2024 DOI:
https://doi.org/10.4143/crt.2023.1294
Web of Science 2
Crossref 2
Tissue and Plasma-Based Highly Sensitive Blocker Displacement Amplicon Nanopore Sequencing for
EGFR
Mutation
s in Lung Cancer
Patinya Akkhasutthikun, Pornchai Kaewsapsak, Pattaraporn Nimsamer, Pavit Klomkliew, Suthida Visedthorn, Pragwalai Chanchaem, Chinachote Teerapakpinyo, Sunchai Payungporn, Sutima Luangdilok
Cancer Res Treat.
2024;56(2):455-463. Published online November 20, 2023 DOI:
https://doi.org/10.4143/crt.2023.1108
Rare cancer
Clinical Features of Li-Fraumeni Syndrome in Korea
Ran Song, Sun-Young Kong, Wonyoung Choi, Eun-Gyeong Lee, Jaeyeon Woo, Jai Hong Han, Seeyoun Lee, Han-Sung Kang, So-Youn Jung
Cancer Res Treat.
2024;56(1):334-341. Published online August 9, 2023 DOI:
https://doi.org/10.4143/crt.2023.794
Breast cancer
Short-term Impact of Hormone Replacement Therapy on Risk of Breast Cancer in
BRCA
Mutation
Carriers: A Nationwide Study in South Korea
Hye Yeon Kim, Jisoo Park, Seok Joo Moon, Sohyeon Jeong, Jin Hwa Hong, Jae Kwan Lee, Geum Joon Cho, Hyun-Woong Cho
Cancer Res Treat.
2024;56(1):143-148. Published online August 16, 2023 DOI:
https://doi.org/10.4143/crt.2023.653
Web of Science 1
Crossref 1
Lung and Thoracic cancer
Clinical Impact of Genomic and Pathway Alterations in Stage I
EGFR
-Mutant Lung Adenocarcinoma
Jae Seok Lee, Eun Kyung Kim, Kyung A Kim, Hyo Sup Shim
Cancer Res Treat.
2024;56(1):104-114. Published online July 24, 2023 DOI:
https://doi.org/10.4143/crt.2023.728
Clinical Validation of the Unparalleled Sensitivity of the Novel Allele-Discriminating Priming System Technology–Based
EGFR
Mutation
Assay in Patients with Operable Non–Small Cell Lung Cancer
Il-Hyun Park, Dae-Soon Son, Yoon-La Choi, Ji-Hyeon Choi, Ji-Eun Park, Yeong Jeong Jeon, Minseob Cho, Hong Kwan Kim, Yong Soo Choi, Young Mog Shim, Jung Hee Kang, Suzy Park, Jinseon Lee, Sung-Hyun Kim, Byung-Chul Lee, Jhingook Kim
Cancer Res Treat.
2024;56(1):81-91. Published online June 20, 2023 DOI:
https://doi.org/10.4143/crt.2023.408
Web of Science 2
Crossref 2
Lazertinib versus Gefitinib as First-Line Treatment for
EGFR
-mutated Locally Advanced or Metastatic NSCLC: LASER301 Korean Subset
Ki Hyeong Lee, Byoung Chul Cho, Myung-Ju Ahn, Yun-Gyoo Lee, Youngjoo Lee, Jong-Seok Lee, Joo-Hang Kim, Young Joo Min, Gyeong-Won Lee, Sung Sook Lee, Kyung-Hee Lee, Yoon Ho Ko, Byoung Yong Shim, Sang-We Kim, Sang Won Shin, Jin-Hyuk Choi, Dong-Wan Kim, Eun Kyung Cho, Keon Uk Park, Jin-Soo Kim, Sang Hoon Chun, Jangyoung Wang, SeokYoung Choi, Jin Hyoung Kang
Cancer Res Treat.
2024;56(1):48-60. Published online June 27, 2023 DOI:
https://doi.org/10.4143/crt.2023.453
Crossref 1
Gastrointestinal cancer
Specific
Mutation
s in
APC
, with Prognostic Implications in Metastatic Colorectal Cancer
Huan Peng, Jun Ying, Jia Zang, Hao Lu, Xiaokai Zhao, Pengmin Yang, Xintao Wang, Jieyi Li, Ziying Gong, Daoyun Zhang, Zhiguo Wang
Cancer Res Treat.
2023;55(4):1270-1280. Published online April 24, 2023 DOI:
https://doi.org/10.4143/crt.2023.415
Web of Science 2
Crossref 2
Lung and Thoracic cancer
Should We Perform Repeated Re-biopsy for the Detection of T790M
Mutation
?
Saerom Kim, Soo Han Kim, Jinmi Kim, Mi-Hyun Kim, Min Ki Lee, Jung Seop Eom
Cancer Res Treat.
2023;55(4):1190-1197. Published online April 17, 2023 DOI:
https://doi.org/10.4143/crt.2023.320
Web of Science 2
Crossref 3
Genomic Characteristics and the Potential Clinical Implications in Oligometastatic Non–Small Cell Lung Cancer
Rongxin Liao, Kehong Chen, Jinjin Li, Hengqiu He, Guangming Yi, Mingfeng Huang, Rongrong Chen, Lu Shen, Xiaoyue Zhang, Zaicheng Xu, Zhenzhou Yang, Yuan Peng
Cancer Res Treat.
2023;55(3):814-831. Published online January 12, 2023 DOI:
https://doi.org/10.4143/crt.2022.1315
EGFR
Mutation
–Positive Unresectable Stage III Non-Squamous Lung Cancer Is Associated with a High Incidence of Brain Metastasis
Hongsik Kim, Sehhoon Park, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn
Cancer Res Treat.
2023;55(2):498-505. Published online October 4, 2022 DOI:
https://doi.org/10.4143/crt.2022.388
Web of Science 1
Crossref 1
Real World Characteristics and Clinical Outcomes of
HER2
-Mutant Non–Small Cell Lung Cancer Patients Detected by Next-Generation Sequencing
Beung-Chul Ahn, Ye-Jeong Han, Hye Ryun Kim, Min Hee Hong, Byoung Chul Cho, Sun Min Lim
Cancer Res Treat.
2023;55(2):488-497. Published online November 9, 2022 DOI:
https://doi.org/10.4143/crt.2022.359
Web of Science 6
Crossref 5
General
Validation and Clinical Application of ONCOaccuPanel for Targeted Next-Generation Sequencing of Solid Tumors
Moonsik Kim, Changseon Lee, Juyeon Hong, Juhee Kim, Ji Yun Jeong, Nora Jee-Young Park, Ji-Eun Kim, Ji Young Park
Cancer Res Treat.
2023;55(2):429-441. Published online November 25, 2022 DOI:
https://doi.org/10.4143/crt.2022.891
Web of Science 6
Crossref 7
Utilizing Plasma Circulating Tumor DNA Sequencing for Precision Medicine in the Management of Solid Cancers
Yongjun Cha, Sheehyun Kim, Sae-Won Han
Cancer Res Treat.
2023;55(2):367-384. DOI:
https://doi.org/10.4143/crt.2023.446
Web of Science 6
Crossref 5
Breast cancer
Genomic Signatures from Clinical Tumor Sequencing in Patients with Breast Cancer Having Germline
BRCA1/2
Mutation
Ju Won Kim, Hyo Eun Kang, Jimi Choi, Seung Gyu Yun, Seung Pil Jung, Soo Yeon Bae, Ji Young You, Yoon-Ji Choi, Yeul Hong Kim, Kyong Hwa Park
Cancer Res Treat.
2023;55(1):155-166. Published online June 8, 2022 DOI:
https://doi.org/10.4143/crt.2021.1567
Web of Science 1
Crossref 1
Lung and Thoracic cancer
Integrin αvβ3 Induces HSP90 Inhibitor Resistance via FAK Activation in
KRAS
-Mutant Non-Small Cell Lung Cancer
Shinkyo Yoon, Hannah Yang, Hyun-Min Ryu, Eunjin Lee, Yujin Jo, Seyoung Seo, Deokhoon Kim, Chang Hoon Lee, Wanlim Kim, Kyung Hae Jung, Sook Ryun Park, Eun Kyung Choi, Sang-We Kim, Kang-Seo Park, Dae Ho Lee
Cancer Res Treat.
2022;54(3):767-781. Published online September 30, 2021 DOI:
https://doi.org/10.4143/crt.2021.651
Web of Science 2
Crossref 3
The Feasibility of Using Biomarkers Derived from Circulating Tumor DNA Sequencing as Predictive Classifiers in Patients with Small-Cell Lung Cancer
Yu Feng, Yutao Liu, Mingming Yuan, Guilan Dong, Hongxia Zhang, Tongmei Zhang, Lianpeng Chang, Xuefeng Xia, Lifeng Li, Haohua Zhu, Puyuan Xing, Hongyu Wang, Yuankai Shi, Zhijie Wang, Xingsheng Hu
Cancer Res Treat.
2022;54(3):753-766. Published online October 5, 2021 DOI:
https://doi.org/10.4143/crt.2021.905
Web of Science 3
Crossref 4
Comparison of the Predictive Power of a Combination versus Individual Biomarker Testing in Non–Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors
Hyojin Kim, Hyun Jung Kwon, Eun Sun Kim, Soohyeon Kwon, Kyoung Jin Suh, Se Hyun Kim, Yu Jung Kim, Jong Seok Lee, Jin-Haeng Chung
Cancer Res Treat.
2022;54(2):424-433. Published online July 7, 2021 DOI:
https://doi.org/10.4143/crt.2021.583
Web of Science 12
Crossref 6
General
Attitudes toward Risk-Reducing Mastectomy and Risk-Reducing Salpingo-oophorectomy among Young, Unmarried, Healthy Women in Korea
Boyoung Park, Dongwon Kim, Jiyoung Kim, Bom Yi Lee, Junghyun Yoon, Sung-Won Kim
Cancer Res Treat.
2022;54(2):375-382. Published online August 9, 2021 DOI:
https://doi.org/10.4143/crt.2021.449
Lung and Thoracic cancer
Acquired Resistance Mechanism of
EGFR
Kinase Domain Duplication to EGFR TKIs in Non–Small Cell Lung Cancer
Chaelin Lee, Miso Kim, Dong-Wan Kim, Tae Min Kim, Soyeon Kim, Sun-Wha Im, Yoon Kyung Jeon, Bhumsuk Keam, Ja-Lok Ku, Dae Seog Heo
Cancer Res Treat.
2022;54(1):140-149. Published online May 3, 2021 DOI:
https://doi.org/10.4143/crt.2021.385
Web of Science 4
Crossref 5
Breast Cancer
Talazoparib Versus Chemotherapy in Patients with HER2-negative Advanced Breast Cancer and a Germline
BRCA1/2
Mutation
Enrolled in Asian Countries: Exploratory Subgroup Analysis of the Phase III EMBRACA Trial
Kyung-Hun Lee, Joohyuk Sohn, Annabel Goodwin, Tiziana Usari, Silvana Lanzalone, Seock-Ah Im, Sung-Bae Kim
Cancer Res Treat.
2021;53(4):1084-1095. Published online March 24, 2021 DOI:
https://doi.org/10.4143/crt.2020.1381
Web of Science 6
Crossref 7
General
Pan-cancer Analysis of Tumor
Mutation
al Burden and Homologous Recombination DNA Damage Repair Using Targeted Next-Generation Sequencing
Hai-Yun Wang, Ling Deng, Ying-Qing Li, Xiao Zhang, Ya-Kang Long, Xu Zhang, Yan-Fen Feng, Yuan He, Tao Tang, Xin-Hua Yang, Fang Wang
Cancer Res Treat.
2021;53(4):973-982. Published online February 18, 2021 DOI:
https://doi.org/10.4143/crt.2020.798
Web of Science 7
Crossref 7
Gynecologic cancer
Uptake of Family-Specific
Mutation
Genetic Testing Among Relatives of Patients with Ovarian Cancer with
BRCA1
or
BRCA2
Mutation
Go Woon Jeong, Wonkyo Shin, Dong Ock Lee, Sang-Soo Seo, Sokbom Kang, Sang-Yoon Park, Myong Cheol Lim
Cancer Res Treat.
2021;53(1):207-211. Published online August 11, 2020 DOI:
https://doi.org/10.4143/crt.2020.364
Web of Science 7
Crossref 7
Lung cancer
A Phase II Trial of Osimertinib as the First-Line Treatment of Non–Small Cell Lung Cancer Harboring Activating
EGFR
Mutation
s in Circulating Tumor DNA: LiquidLung-O-Cohort 1
Cheol-Kyu Park, Hyun-Ju Cho, Yoo-Duk Choi, In-Jae Oh, Young-Chul Kim
Cancer Res Treat.
2021;53(1):93-103. Published online September 21, 2020 DOI:
https://doi.org/10.4143/crt.2020.459
Web of Science 4
Crossref 4
Gynecologic cancer
Germline and Somatic
BRCA1/2
Gene
Mutation
al Status and Clinical Outcomes in Epithelial Peritoneal, Ovarian, and Fallopian Tube Cancer: Over a Decade of Experience in a Single Institution in Korea
Se Ik Kim, Maria Lee, Hee Seung Kim, Hyun Hoon Chung, Jae-Weon Kim, Noh Hyun Park, Yong-Sang Song
Cancer Res Treat.
2020;52(4):1229-1241. Published online July 27, 2020 DOI:
https://doi.org/10.4143/crt.2020.557
Web of Science 11
Crossref 3
Gastrointestinal cancer
A Phase II Study of Avelumab Monotherapy in Patients with Mismatch Repair–Deficient/Microsatellite Instability–High or
POLE
-Mutated Metastatic or Unresectable Colorectal Cancer
Jwa Hoon Kim, Sun Young Kim, Ji Yeon Baek, Yong Jun Cha, Joong Bae Ahn, Han Sang Kim, Keun-Wook Lee, Ji-Won Kim, Tae-You Kim, Won Jin Chang, Joon Oh Park, Jihun Kim, Jeong Eun Kim, Yong Sang Hong, Yeul Hong Kim, Tae Won Kim
Cancer Res Treat.
2020;52(4):1135-1144. Published online April 24, 2020 DOI:
https://doi.org/10.4143/crt.2020.218
Web of Science 56
Crossref 33
Lung cancer
Genetic Alterations in Preinvasive Lung Synchronous Lesions
Soyeon Ahn, Jisun Lim, Soo Young Park, Hyojin Kim, Hyun Jung Kwon, Yeon Bi Han, Choon-Taek Lee, Sukki Cho, Jin-Haeng Chung
Cancer Res Treat.
2020;52(4):1120-1134. Published online June 5, 2020 DOI:
https://doi.org/10.4143/crt.2020.307
Web of Science 2
Crossref 1
Detection of Germline
Mutation
s in Breast Cancer Patients with Clinical Features of Hereditary Cancer Syndrome Using a Multi-Gene Panel Test
Hee-Chul Shin, Han-Byoel Lee, Tae-Kyung Yoo, Eun-Shin Lee, Ryong Nam Kim, Boyoung Park, Kyong-Ah Yoon, Charny Park, Eun Sook Lee, Hyeong-Gon Moon, Dong-Young Noh, Sun-Young Kong, Wonshik Han
Cancer Res Treat.
2020;52(3):697-713. Published online February 4, 2020 DOI:
https://doi.org/10.4143/crt.2019.559
Web of Science 29
Crossref 28
PIK3CA
H1047R
Mutation
Associated with a Lower Pathological Complete Response Rate in Triple-Negative Breast Cancer Patients Treated with Anthracycline-Taxane–Based Neoadjuvant Chemotherapy
Sanxing Guo, Sibylle Loibl, Gunter von Minckwitz, Silvia Darb-Esfahani, Bianca Lederer, Carsten Denkert
Cancer Res Treat.
2020;52(3):689-696. Published online February 4, 2020 DOI:
https://doi.org/10.4143/crt.2019.497
Web of Science 28
Crossref 29
1
2
3
Journal Impact Factor 4.1